Valero Energy Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Valero Energy Corporation trades at $314.8 (market cap $93.03B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: Valero Energy Corporation pays a 1.53% dividend while State Street SPDR S&P Biotech ETF pays none, and Valero Energy Corporation is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| VLO | XBI | |
|---|---|---|
Market Cap | $93.03B | — |
Sector | Energy | Broad Market / Factor |
52-Week High | $313.31 | $164.28 |
52-Week Low | $131.77 | $85.16 |
Enterprise Value | $98.79B | — |
Dividend Yield | 1.53% | — |
Signals from Pluang's Aura AI — not financial advice
Valero Energy (VLO) trades at $314.80, up 1.66% today and near its 52-week high, with a bullish technical outlook supported by strong moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 expected at $10.13 EPS. Revenue declined to $122.69B in 2025, but net income margin improved to 3.37%, while valuation ratios like P/E of 22.89 and P/S of 0.77 reflect moderate pricing relative to peers. Recent news highlights robust refining margins and dividend declarations of $1.20 per share.
VLO's outlook is positive due to elevated crack spreads and strong fuel demand, though revenue declines pose a risk. Analyst consensus is bullish with a $285.38 price target, but high RSI levels suggest potential near-term pullbacks. Investment appeal lies in earnings momentum and shareholder returns, balanced against exposure to volatile energy markets and refining margins.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →